WFK-13241-65892
2 vaccinations
2 coded responses
10 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 254 / WV
- Registered
- 2021-10-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-28
Dose 1 — Pfizer-BioNTech
-
2021-10-05
Registered in v-safe
- 2021-10-05
-
2021-10-12
Survey response — day 14, dose 1MedDRA: Vitreous floaters — Feeling: GoodFree text: Floaters in vision field at timesMedDRA releases: 2024-11 · check-in free text available
- 2021-10-19
-
2021-10-20
Dose 2 — Pfizer-BioNTech
- 2021-10-23
-
2021-10-24
Survey response — days 1–6 daily, dose 2MedDRA: Chills — Feeling: GoodFree text: Chills night of vaccine.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-27
- 2021-11-05
- 2021-11-24
- 2022-01-21
- 2022-10-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-28 | Pfizer-BioNTech | No |
| 2 | 2021-10-20 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 1
Symptoms: Floaters in vision field at times
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Chills night of vaccine.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Vitreous floaters | · | · | ✓ |
| SRO | Chills | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release